Introduction
Hormone replacement therapy has been available for about 40 years. The first placebo controlled efficacy study was reported in 1950 [l] . Since bone loss [2-41 and death from coronary heart disease [5-71. Nevertheless, several authors report a low prevalence of HRT use [8,91. Several factors that influence the decision to use HRT have been reported in the literature. The regular withdrawal bleeding as a result of the cyclic oestrogen/progestagen therapy is often experienced as unacceptable [lO,l 11 . Also, fear of cancer seems to be an important reason to refrain from HRT [12] . In contrast, women who are interested in health promotion and disease prevention measures are more willing to take estrogens [ 13) . Furthermore, a higher rate of medical consultations, a belief in the efficacy of medical treatment (especially hormonal treatment), experience of hot flushes, women's overall experience of menopause, parity, education and smoking behaviour may influence the use of HRT [ 14-151. Next to these factors which are related to the women, doctor-related factors may be equally important, e.g. the judgment of the physicians concerning HRT leads to considerable differences in prescribing behaviour and a clear inter-doctor variability has been documented [ 16,171. The aim of this study was to estimate the cumulative incidence of first HRT prescription and the influence of the woman's well-being, attitude towards menopause, menopausal status and other variables on first HRT prescription in a population at large during a 9 month follow-up period. For women as well as their doctors the so-called typical complaints are probably the major indication for HRT [8, 18, 19] . Therefore, the incidence and determinants of HRT were studied among women with and without these complaints.
Subjects and methods

Recruitment
This study is part of a larger study aimed at assessing the relationships between climacteric, well-being, women's attitude towards menopause and medical attention. The methods applied to measure well-being and attitude towards menopause have been reported in detail elsewhere [20, 21] . In short, from the municipal authorities of Krimpen aan den Ijssel, a commuter suburb of Rotterdam with approximately 28 000 inhabitants, names and addresses of all 2729 women aged between 45-60 years were obtained. In May 1990 they were sent a questionnaire; 1947 women responded (response 71.3%). A random sample (N = 55) was taken of the non-respondents in order to evaluate the representativity of the respondent group. They were approached by telephone and 52 participated (response 95%). The comparison between respondents and nonrespondents revealed no statistically significant differences in age, menopausal status, hysterectomy, estrogen therapy, level of education, work outside the home or medical attention.
To measure the cumulative incidence of first HRT prescriptions, assistance was given by the two pharmacies in Krimpen aan den Ijssel. Both pharmacies are computerized. Of the women who returned the questionnaire, the 220 women (prevalence 11.5%) who had used estrogen therapy within 6 months preceding answering the questionnaire and the 7 women who used progestagens without estrogens were excluded. A further 31 women could not be traced in the pharmacies' database. The remaining 1689 women were registered at the pharmacies, included in the study and followed for a period of 9 months. The followup period lasted from July 1st 1990 until April 1st 1991.
The study received approval from the Medical Ethical Committee of the Erasmus University and Academic Hospital Dijkzigt in Rotterdam.
Measurements
General well-being was measured by two validated inventories: the 'Inventory of Subjective Health' (ISH) and the 'Sickness Impact Profile' (SIP). The ISH has proven to be a sensitive instrument to detect health problems [22-241. The ISH includes 49 items, concerning the experience in the past 2 weeks, for example; pains in the chest, trembling hands, headache, sneezing and loss of appetite. On every item the respondent is asked whether she has experienced this during the last 2 weeks. All items must be answered with either 'yes' or 'no'. The maximum score is 49. The SIP was developed in the United States as a behaviourally based measure of the impact of sickness [25] . In this study, the Dutch validated version has been used [26] . Both SIP overall scores and SIP category scores can discriminate between sub-samples of respondents. We have chosen three category scores which measure psycho-social impact on well-being: emotions, feelings and sensations (9 items), social interaction (18 items) and intellectual functioning (10 items). All items are rated on a scaling factor. This scaling permits the calculation of three SIP percent category scores. A percentage of 100 means maximal impairment on the corresponding category score.
Three attitude clusters towards menopause were distinguished: two clusters encompass items reflecting the idea that 'menopause is advantageous' and 'menopause is disadvantageous' and one cluster encompasses items reflecting the idea that 'menopause should be treated (medically)' [21] . The women were asked to rate their opinion on all items on a scale ranging from 1 (totally agree) to 5 (totally disagree). Mean scores per cluster were computed.
To ascertain menopausal status according to last menstrual bleeding, women were classified into pre-, peri-and postmenopausal according to menstrual history. Premenopausal women were women having a regular menstruation pattern in the preceding 12 months. Women were considered perimenopausal when irregular cycles or amenor-rhoa had developed in the 12 months prior to the questionnaire. Women were classified as postmenopausal if last menstrual bleeding occurred at least 12 months ago. Women who had undergone hysterectomy were categorized as a separate group.
The women were also asked to rate their climacteric phase themselves by choosing one of the following live categories: 'I have not reached the menopause' (classified as premenopausal), 'I have just reached the menopause', 'I am in the middle of the menopause', 'I have reached the end of the menopause' (all three categories classified as perimenopausal), 'I reached the menopause long ago'(classilied as postmenopausal).
The methods used to measure the other potential determinants of the initial HRT such as body mass index, smoking behaviour, parity, age, general practice are shown in Table 1 .
Women were categorized as having typical (climacteric) complaints when they reported one or more of the following symptoms on the questionnaire: hot flushes, severe sweating, vaginal dryness or menstruation disturbances. The presence of severe sweating and vaginal dryness were assessed by using both a closed and an open question, whereas the presence of hot flushes and menstruation disturbances were assessed using an open question only. The closed questions were incorporated in a symptom checklist, where the women could encircle either yes or no when they had regularly experienced a symptom during the last two weeks. In the open question the women could indicate any symptom they experienced during the last 4 weeks.
Analysis
The cumulative incidence of first HRT prescriptions during 9 months was computed. Linear variables were dichotomized around the median. The association between possible determinants and first HRT prescriptions was studied by means of the x2-test. Determinants that were associated with first HRT prescription on a P < 0.10 level were then included in a logistic regression analysis to ascertain the relative contributions. For all ordinal and nominal variables dummy variables were constructed to detect non-linear effects. The backward stepwise procedure was used retaining only variables that contributed on a P < 0.10 level to the prediction of first HRT prescriptions.
As the relationships between the determinants and first HRT prescriptions may be modified by the presence of typical (climacteric) complaints, subgroup analyses were performed for the women without and women with typical complaints.
Results
The 9 month cumulative incidence of first HRT prescriptions was 6.2% (104 women). This equals a 1 year cumulative incidence of 8.2%. The incidence of first HRT prescriptions among women without typical complaints at baseline was 4.4%, whereas the incidence for women with typical complaints was 8.0%. Table 1 shows the relationship between first HRT prescriptions and possible determinants. Only statistically significant associations are reported below. Two measures of well-being predicted first HRT prescriptions: women below the median of the ISH -i.e. the half of women that feel relatively well -had an incidence of 4.4% whereas the women above the median of the ISH had an incidence of 9.0%. For the SIP -emotions, feelings and sensations, these figures were 5.1% and 8.8%, respectively. From the attitude measurements, the cluster 'menopause should be treated (medically)' was related to HRT prescription. Women who thought more positively had an incidence of 8.5%, whereas the other women had an incidence of 3.6%. Only the menopausal status according to the women themselves was associated with first HRT. Of the premenopausal women 7.0%, of the perimenopausal women 7.1% and of the postmenopausal women 3.3% started using HRT within the 9 months.
Determinants offirst HRTprescriptions for all women
Furthermore, women who were younger, women who smoked more than 15 cigarettes per day, women who formerly used the contraceptive pill and women who were hysterectomized were more often prescribed HRT. Women who were enlisted in general practice C had the highest inci- dence of first HRT use (8.10/o), while women in general practice A had the lowest 9 month prescription rate (3.3%).
The results of the multivariate logistic regression analysis are shown in Table 2 . Within the 9 months of the study, women with typical complaints were prescribed HRT 1.7 times (95% CI 0.9; 3.0) more often than women without these complaints. The likelihood of HRT prescription for women above the median of the ISH was 2.0 (95% CI 1.1; 3.6) times higher than for women below the median. For the women who thought more positively about the attitude cluster 'menopause should be treated' the odds ratio equalled 2.7 (95% CI 1.5; 4.9) compared to the women who thought more negatively. Women who smoked more than 15 cigarettes a day had an odds ratio of 2.2 (95% CI 1.1; 4.6) compared to women who had never smoked. Former use of the contraceptive pill resulted in a 2.3 (95% CI 1.1; 4.6) times higher prescription rate of HRT within the 9 months compared to women who never used the pill.
Determinants offirst HRTfor women with and without typical complaints
In the multivariate analyses (Table 2) all relationships between determinants and HRT prescription appeared to be modified by the presence of typical complaints. For women without typical complaints the ISH and the former use of the contraceptive pill were determinants of initial HRT prescription. Women above the median of the ISH had a 5.5 (95% CI 1.9; 15.5) higher rate of HRT than women below the median, while for former users of the contraceptive pill the odds ratio was 4.6 (95% CI 1.0; 20.5).
For the women with typical complaints the attitude cluster 'menopause should be treated' was related to HRT prescription. Women who thought more positively about treatment had an odds ratio of 3.8 (95% CI 1.8; 8.0) compared to women who thought more negatively.
Discussion
In this follow-up study of 1689 women aged 45-60 years in an open population, the 9 month cumulative incidence of first hormonal replacement therapy prescriptions was 6.2%. When the independent effects of several determinants were studied by means of a logistic regression analysis this incidence appeared to be higher for women (i) with typical complaints, (ii) with a lower level of well-being as measured by the ISH, (iii) with a more positive attitude towards 'the menopause should be treated', (iv) smoking more than 15 cigarettes a day and (v) who formerly used the contraceptive pill.
In this 9 month study a cumulative incidence of 6.2% of first HRT was established, whereas the prevalence of HRT use at baseline was 11.5%. This implies that either the prevalence of HRT is rapidly increasing or that many women stop taking HRT. We were able to verify these options at the two pharmacies where the women were still registered. The pharmacies reported that one year and 9 months after the questionnaire 68 of the 103 (66%) women were no longer prescribed HRT (one woman moved). Therefore, the problem of a low prevalence of HRT as stated by several studies [8, 9, 15] might be attributed to the problem of continuating rather than starting HRT.
Several determinants of HRT prescription that have been found in our study are in line with previous findings. An association between general well-being and HRT has not been reported as a determinant of HRT in other studies. However, these studies were cross-sectional and therefore the level of well-being may already have been influenced by HRT [14, 15] . The relationship between attitude towards treatment and HRT has been found before [27] . Apparently, the belief in the efficacy of medical treatment of the menopause is at least as important as the presence of typical complaints. The relationship between smoking behaviour and HRT was ascertained in one study [28] , but absent in another study [ 151. Perhaps women who smoke may therefore experience typical complaints more intensely. In several earlier studies, the former use of the contraceptive pill was a determinant of HRT use [ 151. Probably, once a woman has decided to use hormones with a contraceptive purpose, she has less fear of cancer and other adverse effects.
In our study, hysterectomy was, in contrast to other studies [15, 29] , a determinant in the univariate analysis only. Once well-being, smoking behaviour and/or former use of the pill were taken into account by means of the logistic regression analysis, the prediction of HRT prescription did not depend on hysterectomy. The same was found for the SIP emotions, feelings and sensations, the menopausal status according to the woman, age and general practice.
The cumulative incidence for women with typical (climacteric) complaints was 8.0% versus 4.4% for women without typical complaints. Hence, for the majority of the women a therapeutic indication existed. For women without and with typical complaints it appears that the prediction of HRT use is determined by different factors, i.e. a lower level of well-being and the former use of the contraceptive pill for women without these complaints and a positive attitude towards 'menopause should be treated' for women with these complaints.
It is remarkable that a lower level of well-being as measured by the ISH determined HRT prescription (odds ratio = 5.5) for women without typical complaints. As yet, no clear views exist about the beneficial effect of HRT on well-being in the absence of typical symptoms. From this we may tentatively conclude that a low level of well-being as measured by the ISH may influence the woman and/or her physician in the process leading to HRT prescription. In a study of Hunt a considerable influence of patient's demand on HRT prescription was apparent (21% of all prescriptions) [ 191. This conclusion is also supported by the divergence in HRT prescription rates between the general practices, especially for women without typical complaints.
Ferguson also observed differences between physicians in HRT prescription [27] . When typical complaints are present, the prescription of HRT mainly depends on the woman's attitude towards 'menopause should be treated' and not on her experienced level of well-being.
To our knowledge this is the first study to assess the cumulative incidence of HRT and its determinants in an unselected population. By gathering the data from the pharmacists, neither the women's nor the doctor's attention was drawn to HRT prescription. The information about HRT provided in the last part of the questionnaire might have influenced the incidence of HRT in the first few months after the filling out of the questionnaire. However, we did not find such an increase in the prescription. Another limitation of this study is the possibility of a change in typical complaints during the 9 month follow-up. Women were categorized as women with or without typical complaints according to the presence of these symptoms at the time of the questionnaire. Subsequent changes in the experience of these complaints, which were not measured, may have been of influence on the prescription of HRT. Most likely this resulted in an under-estimation of the relationships reported in the separate analyses. Another limitation is the fact that we measured delivery of HRT prescriptions and not the actual use. Moreover, some women might have incidentally filled HRT prescriptions in other pharmacies than the two present in Krimpen aan den IJssel. As there is a considerable distance to other pharmacies and only 3 1 out of 1947 women could not be traced at either pharmacy this will only have happened in few cases. Nevertheless a slight underestimation of the cumulative incidence of HRT may be present. Finally, although we evaluated most variables known to possibly influence the prescription of HRT, some other factors such as those related to the physician were not measured.
It may be concluded that the cumulative incidence of first HRT prescription is high, but that the majority of the women stop taking HRT within 2 years, which implies that most indications are rather therapeutic than preventive. When typical complaints are absent, women with a level of well-being above the median are prescribed HRT live times more frequently. The question arises whether for these women the indication is therapeutic, preventive or equivocal, For women with typical complaints the doctor's prescription is primarily related to the woman's attitude towards (medical) treatment of the menopause. The process of decision-making about starting and continuation of HRT is complex, depending on a variety of determinants modified by the presence of the typical climacteric complaints. Insight of this process may contribute to a more rational prescription of HRT.
